The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice.
<h4>Background</h4>MiR-221 and miR-222 are two highly homologous microRNAs whose upregulation has been recently described in several types of human tumors, for some of which their oncogenic role was explained by the discovery of their target p27, a key cell cycle regulator. We previously...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/62cb84e6174e43b3b3b5c72a93f37f58 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:62cb84e6174e43b3b3b5c72a93f37f58 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:62cb84e6174e43b3b3b5c72a93f37f582021-11-25T06:18:01ZThe inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice.1932-620310.1371/journal.pone.0004029https://doaj.org/article/62cb84e6174e43b3b3b5c72a93f37f582008-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19107213/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>MiR-221 and miR-222 are two highly homologous microRNAs whose upregulation has been recently described in several types of human tumors, for some of which their oncogenic role was explained by the discovery of their target p27, a key cell cycle regulator. We previously showed this regulatory relationship in prostate carcinoma cell lines in vitro, underlying the role of miR-221/222 as inducers of proliferation and tumorigenicity.<h4>Methodology/principal findings</h4>Here we describe a number of in vivo approaches confirming our previous data. The ectopic overexpression of miR-221 is able, per se, to confer a high growth advantage to LNCaP-derived tumors in SCID mice. Consistently, the anti-miR-221/222 antagomir treatment of established subcutaneous tumors derived from the highly aggressive PC3 cell line, naturally expressing high levels of miR-221/222, reduces tumor growth by increasing intratumoral p27 amount; this effect is long lasting, as it is detectable as long as 25 days after the treatment. Furthermore, we provide evidence in favour of a clinical relevance of the role of miR-221/222 in prostate carcinoma, by showing their general upregulation in patient-derived primary cell lines, where we find a significant inverse correlation with p27 expression.<h4>Conclusions/significance</h4>These findings suggest that modulating miR-221/222 levels may have a therapeutic potential in prostate carcinoma.Neri MercatelliValeria CoppolaDesirée BonciFrancesca MieleArianna CostantiniMarco GuadagnoliElena BonannoGiovanni MutoGiovanni Vanni FrajeseRuggero De MariaLuigi Giusto SpagnoliMaria Giulia FaraceSilvia Anna CiafrèPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 3, Iss 12, p e4029 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Neri Mercatelli Valeria Coppola Desirée Bonci Francesca Miele Arianna Costantini Marco Guadagnoli Elena Bonanno Giovanni Muto Giovanni Vanni Frajese Ruggero De Maria Luigi Giusto Spagnoli Maria Giulia Farace Silvia Anna Ciafrè The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| description |
<h4>Background</h4>MiR-221 and miR-222 are two highly homologous microRNAs whose upregulation has been recently described in several types of human tumors, for some of which their oncogenic role was explained by the discovery of their target p27, a key cell cycle regulator. We previously showed this regulatory relationship in prostate carcinoma cell lines in vitro, underlying the role of miR-221/222 as inducers of proliferation and tumorigenicity.<h4>Methodology/principal findings</h4>Here we describe a number of in vivo approaches confirming our previous data. The ectopic overexpression of miR-221 is able, per se, to confer a high growth advantage to LNCaP-derived tumors in SCID mice. Consistently, the anti-miR-221/222 antagomir treatment of established subcutaneous tumors derived from the highly aggressive PC3 cell line, naturally expressing high levels of miR-221/222, reduces tumor growth by increasing intratumoral p27 amount; this effect is long lasting, as it is detectable as long as 25 days after the treatment. Furthermore, we provide evidence in favour of a clinical relevance of the role of miR-221/222 in prostate carcinoma, by showing their general upregulation in patient-derived primary cell lines, where we find a significant inverse correlation with p27 expression.<h4>Conclusions/significance</h4>These findings suggest that modulating miR-221/222 levels may have a therapeutic potential in prostate carcinoma. |
| format |
article |
| author |
Neri Mercatelli Valeria Coppola Desirée Bonci Francesca Miele Arianna Costantini Marco Guadagnoli Elena Bonanno Giovanni Muto Giovanni Vanni Frajese Ruggero De Maria Luigi Giusto Spagnoli Maria Giulia Farace Silvia Anna Ciafrè |
| author_facet |
Neri Mercatelli Valeria Coppola Desirée Bonci Francesca Miele Arianna Costantini Marco Guadagnoli Elena Bonanno Giovanni Muto Giovanni Vanni Frajese Ruggero De Maria Luigi Giusto Spagnoli Maria Giulia Farace Silvia Anna Ciafrè |
| author_sort |
Neri Mercatelli |
| title |
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| title_short |
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| title_full |
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| title_fullStr |
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| title_full_unstemmed |
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. |
| title_sort |
inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2008 |
| url |
https://doaj.org/article/62cb84e6174e43b3b3b5c72a93f37f58 |
| work_keys_str_mv |
AT nerimercatelli theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT valeriacoppola theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT desireebonci theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT francescamiele theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT ariannacostantini theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT marcoguadagnoli theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT elenabonanno theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT giovannimuto theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT giovannivannifrajese theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT ruggerodemaria theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT luigigiustospagnoli theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT mariagiuliafarace theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT silviaannaciafre theinhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT nerimercatelli inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT valeriacoppola inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT desireebonci inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT francescamiele inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT ariannacostantini inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT marcoguadagnoli inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT elenabonanno inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT giovannimuto inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT giovannivannifrajese inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT ruggerodemaria inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT luigigiustospagnoli inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT mariagiuliafarace inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice AT silviaannaciafre inhibitionofthehighlyexpressedmir221andmir222impairsthegrowthofprostatecarcinomaxenograftsinmice |
| _version_ |
1718413927925153792 |